Table 7 Inter reliability analysis for the observer agreement among the recommendation categories for the various COVID-19 medications studied. (The various recommendation categories were assessed for the strength of agreement between the investigators and the different drug information resources)
Recommendation categories | Value of k†| 95% Confidence Interval | P-value * | Strength of Agreement |
|---|---|---|---|---|
Can be used | 0.422 | 0.420 – 0.425 | < 0.001 | Moderate |
Individual benefit – risk assessment | 0.215 | 0.213 – 0.218 | < 0.001 | Fair |
Should not be used | 0.415 | 0.413 – 0.417 | < 0.001 | Moderate |
Not classifiable | -0.039 | -0.042 – -0.037 | 0.319 | Poor |
No available information | 0.554 | 0.551 – 0.556 | < 0.001 | Moderate |